NINA FONTENEAUX: Open Payments
NPI 1407390693 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 44 payments from 10 companies in 2025. Trend: 2023 $434 · 2024 $875 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 24 | $583 |
| Phathom Pharmaceuticals, Inc. | 7 | $109 |
| ABBVIE INC. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Ardelyx, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| EVOKE PHARMA, INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: REZDIFFRA, VOQUEZNA, ENTYVIO, CREON, IBSRELA, XIFAXAN, TERLIVAZ, ZENPEP.
Industry payments across TX — which companies pay providers there.
